Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial respiratory chain and associated dehydrogenases constitute the core machinery for cellular energy production and metabolic regulation within the mitochondria [17, 18]. This system includes the four primary complexes of the electron transport chain (Complexes I-IV) and various dehydrogenases, such as succinate dehydrogenase (Complex II), pyruvate dehydrogenase, and dihydroorotate dehydrogenase, which feed electrons into the respiratory chain [10, 14, 16]. Their collective biological function is to drive oxidative phosphorylation, producing ATP while maintaining cellular redox balance and regulating signaling pathways like apoptosis and reactive oxygen species (ROS) production [1, 8, 17]. Dysfunctions in these enzymes are implicated in a wide range of pathologies, including primary mitochondrial diseases (e.g., Leigh syndrome), neurodegenerative disorders, type 2 diabetes, and cancer, where they support the high metabolic demands of tumor cells [3, 6, 18, 19]. Therapeutic interventions target these enzymes for diverse purposes: metformin inhibits Complex I to manage blood glucose, atovaquone targets Complex III for antimalarial activity, and DHODH inhibitors are explored for oncology and autoimmune diseases [6, 12, 15, 16]. However, because these pathways are fundamental to life, pharmacological modulation requires careful management to avoid severe side effects like lactic acidosis or organ-specific toxicity [1, 12]. Overall, the mitochondrial respiratory chain represents a complex but vital therapeutic landscape for addressing both metabolic and degenerative conditions [9, 18].
Inhibition of electron transfer within the respiratory complexes, uncoupling of oxidative phosphorylation from ATP synthesis, modulation of reactive oxygen species production, and restoration of mitochondrial bioenergetics through cofactor supplementation or alternative electron carriers.
14 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial respiratory chain and dehydrogenases (MRC).